BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32945366)

  • 1. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
    Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
    Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.
    Nguyen PN; Tran NTB; Nguyen TPX; Ngo TNM; Lai DV; Deel CD; Hassell LA; Vuong HG
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):431-438. PubMed ID: 33849798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.
    Fukumoto K; Nguyen TB; Chiba S; Sakata-Yanagimoto M
    Cancer Sci; 2018 Mar; 109(3):490-496. PubMed ID: 28889481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
    Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
    Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
    Ondrejka SL; Grzywacz B; Bodo J; Makishima H; Polprasert C; Said JW; Przychodzen B; Maciejewski JP; Hsi ED
    Am J Surg Pathol; 2016 Mar; 40(3):335-41. PubMed ID: 26574844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.
    Wang M; Zhang S; Chuang SS; Ashton-Key M; Ochoa E; Bolli N; Vassiliou G; Gao Z; Du MQ
    Oncotarget; 2017 Mar; 8(11):17763-17770. PubMed ID: 28148900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections.
    Nagao R; Kikuti YY; Carreras J; Kikuchi T; Miyaoka M; Matsushita H; Kojima M; Ando K; Sakata-Yanagimoto M; Chiba S; Nakamura N
    Am J Surg Pathol; 2016 Aug; 40(8):1041-50. PubMed ID: 27158755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.
    Wang C; McKeithan TW; Gong Q; Zhang W; Bouska A; Rosenwald A; Gascoyne RD; Wu X; Wang J; Muhammad Z; Jiang B; Rohr J; Cannon A; Steidl C; Fu K; Li Y; Hung S; Weisenburger DD; Greiner TC; Smith L; Ott G; Rogan EG; Staudt LM; Vose J; Iqbal J; Chan WC
    Blood; 2015 Oct; 126(15):1741-52. PubMed ID: 26268241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.
    Attygalle AD; Dobson R; Chak PK; Vroobel KM; Wren D; Mugalaasi H; Morgan Y; Kaur M; Ahmad R; Chen Z; Naresh KN; Du MQ
    Histopathology; 2022 Apr; 80(5):847-858. PubMed ID: 35064935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
    Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
    Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
    Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
    Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.
    Schwartz FH; Cai Q; Fellmann E; Hartmann S; Mäyränpää MI; Karjalainen-Lindsberg ML; Sundström C; Scholtysik R; Hansmann ML; Küppers R
    J Pathol; 2017 Jun; 242(2):129-133. PubMed ID: 28337768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for
    Hsu YT; Wang YC; Chen RY; Hung LY; Li SS; Yen CC; Chen TY; Medeiros LJ; Chang KC
    Leuk Lymphoma; 2020 May; 61(5):1108-1118. PubMed ID: 31870198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNMT3A
    Zheng J; Wang Z; Pan X; Zhang Z; Li H; Deng X; Liu P; Zhang Q; Na F; Chen C; Niu T; Liu Y
    Oncogene; 2023 Jun; 42(23):1940-1950. PubMed ID: 37127775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing.
    Dupuy A; Lemonnier F; Fataccioli V; Martin-Garcia N; Robe C; Pelletier R; Poullot E; Moktefi A; Mokhtari K; Rousselet MC; Traverse-Glehen A; Delarue R; Tournilhac O; Delfau-Larue MH; Haioun C; Ortonne N; Copie-Bergman C; de Leval L; Pujals A; Gaulard P
    J Mol Diagn; 2018 Sep; 20(5):677-685. PubMed ID: 29981867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
    Odejide O; Weigert O; Lane AA; Toscano D; Lunning MA; Kopp N; Kim S; van Bodegom D; Bolla S; Schatz JH; Teruya-Feldstein J; Hochberg E; Louissaint A; Dorfman D; Stevenson K; Rodig SJ; Piccaluga PP; Jacobsen E; Pileri SA; Harris NL; Ferrero S; Inghirami G; Horwitz SM; Weinstock DM
    Blood; 2014 Feb; 123(9):1293-6. PubMed ID: 24345752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
    Tanzima Nuhat S; Sakata-Yanagimoto M; Komori D; Hattori K; Suehara Y; Fukumoto K; Fujisawa M; Kusakabe M; Matsue K; Wakamatsu H; Shimadzu M; Chiba S
    Cancer Sci; 2018 May; 109(5):1682-1689. PubMed ID: 29493850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma.
    Sakata-Yanagimoto M; Nakamoto-Matsubara R; Komori D; Nguyen TB; Hattori K; Nanmoku T; Kato T; Kurita N; Yokoyama Y; Obara N; Hasegawa Y; Shinagawa A; Chiba S
    Ann Hematol; 2017 Sep; 96(9):1471-1475. PubMed ID: 28634614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
    Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
    Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
    Leca J; Lemonnier F; Meydan C; Foox J; El Ghamrasni S; Mboumba DL; Duncan GS; Fortin J; Sakamoto T; Tobin C; Hodgson K; Haight J; Smith LK; Elia AJ; Butler D; Berger T; de Leval L; Mason CE; Melnick A; Gaulard P; Mak TW
    Cancer Cell; 2023 Feb; 41(2):323-339.e10. PubMed ID: 36736318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.